NIH-funded research R21 grant

New testing methods for detecting syphilis infections.

Official title: Rapid and Ultrasensitive aptamer-based detection technologies for T. pallidum

Funded at University of Washington · NIH-10942579 · Data updated 2026-11-12

This study is working on a quick and super-sensitive test for syphilis, which will make it easier and more accurate for people to get diagnosed, whether they are adults or newborns.

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionUniversity of Washington
NIH-funded
Lab location1 site (Seattle, United States)
Project startAugust 1, 2024
Project endJune 30, 2026
Funding year2024
Award (this year)$233,250
NIH project number1R21AI184484-01
Project IDNIH-10942579 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are adults who may be at risk for syphilis infection or those who are pregnant and require testing for congenital syphilis.

Less likely to help

Patients who are not at risk for syphilis or those who have already been diagnosed and treated for the infection may not benefit from this research.

What this research studies

This research focuses on developing a rapid and ultrasensitive diagnostic test for Treponema pallidum, the bacteria that causes syphilis. The current testing methods are often slow, expensive, and can produce inaccurate results, leading to missed diagnoses. By utilizing aptamers—short DNA molecules that can bind to specific targets—this project aims to create a more efficient point-of-care testing solution that can be used widely and easily. This innovative approach seeks to improve the speed and accuracy of syphilis diagnosis, particularly in both adult and congenital cases.

Why it matters

Potential benefit: If successful, this research could lead to faster and more accurate diagnoses of syphilis, improving patient outcomes and reducing the public health threat posed by this infection.

How similar studies have gone: Previous research has shown promise in using aptamer-based technologies for diagnostics, indicating potential success for this novel approach.

Where this research is happening

  • University of Washington
    Seattle, United States
    Active

Researchers

  • Principal investigator: Salipante, Stephen J — University of Washington
  • Study coordinator: Salipante, Stephen J

Related research

Other NIH-funded projects on the same topics.

  • Making genetic testing more accessible to the public

    This study is all about making it easier for people at risk of certain cancers, like breast, ovarian, and colon cancers, to get genetic testing, so we can find out what helps them access these important services and understand how they can benefit from them.

    NIH research University of Washington · Seattle, United States · NIH-9845571

  • Breast cancer diagnosis in low-resource settings using millifluidics and fast digital imaging in Ghana

    A new project will test a fast, low-cost way to diagnose breast cancer at the point of care in Ghana using small-batch fluidics and direct digital imaging.

    NIH research University of Washington · Seattle, United States · NIH-11645064

  • Binaural Hearing and Speech in Noise in Children

    This project explores how children hear speech in noisy classrooms using how the two ears work together to see if binaural processing differences explain why some kids struggle more than others.

    NIH research University of Washington · Seattle, United States · NIH-11631484

  • Neural circuits that control pain aversion in the brain

    Researchers are exploring how a specific brain area helps people feel and avoid pain, with potential to lead to better pain treatments.

    NIH research University of Washington · Seattle, United States · NIH-11629742

  • United World Antiviral Research Network (UWARN)

    A collaborative, international effort is testing new virus surveillance and evolution ideas to help people living with HIV and communities in LMICs stay safer from current and emerging viruses.

    NIH research University of Washington · Seattle, United States · NIH-11627864

  • HF endotypes in heart failure using ethical multi-modal AI and molecular data

    A patient-friendly project that uses advanced AI and multiple kinds of health data to identify distinct heart failure subtypes that could guide personalized care.

    NIH research University of Washington · Seattle, United States · NIH-11621806

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.